HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells

  • Authors:
    • Stefania Mardente
    • Emanuela Mari
    • Fabrizio Consorti
    • Cira Di Gioia
    • Rodolfo Negri
    • Marilena Etna
    • Alessandra Zicari
    • Alfredo Antonaci
  • View Affiliations

  • Published online on: September 26, 2012     https://doi.org/10.3892/or.2012.2058
  • Pages: 2285-2289
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Experimental and epidemiological studies have revealed that chronic inflammation contributes to cancer progression and even predisposes to cellular transformation. Inflammatory infiltrates in papillary thyroid cancer include lymphocytes, macrophages and cytokines. High-mobility group box 1 protein (HMGB1) is a late inflammatory cytokine that signals danger to the immune system through the receptor for advanced glycation end-products (RAGE) and Toll-like receptor. The activation of the above receptors results in the secretion of growth, chemotactic and angiogenic factors that contribute to chronic inflammation. In this study, we suggest that apart from the activation of signal transduction pathways by the activation of RAGE, the indirect inhibition of cell cycle regulators [such as phosphatase and tensin homolog (PTEN)] may also cause an increase in cell growth and motility. MicroRNAs (miRNAs) have increasingly been implicated in regulating the malignant progression of cancer. MiR-221 and miR-222 have been found to be deregulated in human papillary thyroid carcinomas. They are involved in cell proliferation through the inhibition of the cell cycle regulator, p27kip1, in human papillary carcinomas. In this study, we show that HMGB1 increases the expression of miR-221 and miR-222 in primary cultures of excised papillary lesions and in an established papillary cancer cell line (BC PAP). The overexpression of oncogenic miR-221 and miR-222 caused by HMGB1 is associated with an increase in malignancy scores, namely cell growth and motility.
View Figures
View References

Related Articles

Journal Cover

December 2012
Volume 28 Issue 6

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Mardente S, Mari E, Consorti F, Di Gioia C, Negri R, Etna M, Zicari A and Antonaci A: HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. Oncol Rep 28: 2285-2289, 2012.
APA
Mardente, S., Mari, E., Consorti, F., Di Gioia, C., Negri, R., Etna, M. ... Antonaci, A. (2012). HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells. Oncology Reports, 28, 2285-2289. https://doi.org/10.3892/or.2012.2058
MLA
Mardente, S., Mari, E., Consorti, F., Di Gioia, C., Negri, R., Etna, M., Zicari, A., Antonaci, A."HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells". Oncology Reports 28.6 (2012): 2285-2289.
Chicago
Mardente, S., Mari, E., Consorti, F., Di Gioia, C., Negri, R., Etna, M., Zicari, A., Antonaci, A."HMGB1 induces the overexpression of miR-222 and miR-221 and increases growth and motility in papillary thyroid cancer cells". Oncology Reports 28, no. 6 (2012): 2285-2289. https://doi.org/10.3892/or.2012.2058